Form D · Other

HOLLISTER BIOSCIENCES INC.

Hollister, CA · CIK 0001795058

Offering snapshot reported Apr 13, 2021 · SEC filing

Reported sold
$862K
Offering amount: $1.46M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 13, 2021Amendment$862,291No comparisonNot reportedSEC filing
Mar 16, 2021Initial$862,291No comparison15SEC filing
Aug 25, 2020Initial$178,282No comparison11SEC filing
Apr 1, 2020Initial$9,758,871No comparison8SEC filing
Nov 25, 2019Initial$2,722,075No comparison13SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-392441

Source: Form D, filed Apr 13, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Geoffrey Balderson Executive
Amasa Lacy Director, Executive
Patrick C.T. Morris Director
Carl Saling Director, Executive
Alexander Somjen Executive
Anthony Zelen Director

Issuer details

Industry: Other (See others in industry)

Address:
1802 Shelton Drive, #102
Hollister, CA, 95023